EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
B Wang, Y Liu, Z Liao, H Wu, B Zhang… - … hematology & oncology, 2023 - Springer
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death. The
accumulation of genetic and epigenetic changes is closely related to the occurrence and …
accumulation of genetic and epigenetic changes is closely related to the occurrence and …
[HTML][HTML] Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects☆
H Wang, Z Wu, D Cui, Y Shi, B Zhai - Liver Research, 2023 - Elsevier
Local ablation technologies, such as radiofrequency ablation (RFA), microwave ablation
(MWA) and cryoablation, have become a standard treatment option for hepatocellular …
(MWA) and cryoablation, have become a standard treatment option for hepatocellular …
circFAM134B is a key factor regulating reticulophagy-mediated ferroptosis in hepatocellular carcinoma
T Bi, Q Lu, X Pan, F Dong, Y Hu, Z Xu, P Xiu, Z Liu, J Li - Cell Cycle, 2023 - Taylor & Francis
Ferroptosis is an important mode of regulated cell death (RCD). Its inhibition is closely
related to therapeutic resistance and poor prognosis in hepatocellular carcinoma (HCC) …
related to therapeutic resistance and poor prognosis in hepatocellular carcinoma (HCC) …
LINC01343 targets miR-526b-5p to facilitate the development of hepatocellular carcinoma by upregulating ROBO1
S Wu, T Tang, H Zhou, J Huang, X Kang, J Zhang - Scientific Reports, 2023 - nature.com
Long noncoding RNAs (lncRNAs) contribute to hepatocellular carcinoma (HCC) progression
and development. However, the function and molecular mechanisms of action of LINC01343 …
and development. However, the function and molecular mechanisms of action of LINC01343 …
LINC00707 impairs the Natural Killer cell antitumour activity in hepatocellular carcinoma through decreasing YTHDF2 stability
M Wei, L Lu, J Ma, Z Luo, X Tan… - Journal of Cellular and …, 2024 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the fifth most frequently diagnosed cancer and ranks
third in cancer‐related fatalities. The recognized involvement of long noncoding RNAs …
third in cancer‐related fatalities. The recognized involvement of long noncoding RNAs …
Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non–small cell lung cancer: a modelling approach
W Hui, R Song, H Tao, Z Gao, M Zhu, M Zhang, H Wu… - BMC cancer, 2023 - Springer
Background Many studies have explored the cost-effectiveness of immunotherapy versus
chemotherapy alone. However, there is paucity of evidence on direct pharmacoeconomic …
chemotherapy alone. However, there is paucity of evidence on direct pharmacoeconomic …
New Insights on Liver-Directed Therapies in Hepatocellular Carcinoma
CG Dalzell, AC Taylor, SB White - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular carcinoma is the most common type of liver cancer and
affects a significant number of people worldwide. There are multiple treatment options …
affects a significant number of people worldwide. There are multiple treatment options …
LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression
R Wu, W Liu, Q Yang, J Zhang, P Hou, J Xiong, L Wu… - Scientific Reports, 2023 - nature.com
HCC is one of the most common malignant tumors worldwide. Although traditional treatment
methods have been improved in recent years, the survival rate of HCC patients has not been …
methods have been improved in recent years, the survival rate of HCC patients has not been …
LncRNA RP11-620J15. 3 promotes HCC cell proliferation and metastasis by targeting miR-326/GPI to enhance glycolysis
C Liu, K Xu, J Liu, C He, P Liu, Q Fu, H Zhang, T Qin - Biology Direct, 2023 - Springer
Background Accumulating studies have demonstrated that the Warburg effect plays a central
role in the occurrence and development of hepatocellular carcinoma (HCC), albeit the role …
role in the occurrence and development of hepatocellular carcinoma (HCC), albeit the role …
A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma
H Zeng, K Su, X Chen, X Li, L Wen, Y Song, L Chen… - Scientific Reports, 2023 - nature.com
With the advancements in radiotherapy (RT) in recent years, several studies have shown
that RT can significantly prolong the survival of patients with hepatocellular carcinoma …
that RT can significantly prolong the survival of patients with hepatocellular carcinoma …